For those who don’t know Joel Stanley, he’s one of the Stanley brothers, who gained attention by developing Charlotte’s Web: a high CBD strain with very low levels of THC, named after Charlotte Figi. The girls suffers from Dravet Syndrome, a rare form of epilepsy. Featured in a number of documentaries, including CNN’s “Weed: Dr Sanjay Gupta Reports”, the Stanley brothers quickly became famous.
Recently, news broke in the UK that Cannabidiol (CBD), will be scheduled as a medicine. As far as Sensi Seeds is informed, the Medicines and Healthcare Products Regulatory Agency (MHRA) “has reviewed the classification of products containing CBD and found them to meet the definition of a medicinal product”. However, informing the public about this point of view does not necessarily mean that CBD will be removed from the retail market. At least not at this point.
Cannabis News Network takes a closer look at what could happen, should CBD be scheduled as a medicine. The report demonstrates what this would mean for patients, consumers, retail, as well as for GW Pharmaceuticals and their monopoly on medicinal cannabis in the UK. Needless to say that Joel Stanley has an opinion on this subject as well.
Missed the first three episodes of our Irish miniseries? Below the list of instalments: